Ovoca Bio (CDI) (OVB) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
No historical short positions

Ovoca Bio PLC is a biopharmaceutical company focused on women's health, specifically developing novel treatments for female sexual dysfunction. Their lead product, Orenetide (BP-101), is a synthetic peptide administered via nasal spray, designed to treat hypoactive sexual desire disorder in premenopausal women. The company is incorporated in Ireland and operates in Ireland, the UK, and Russia. It is listed in London under the ticker OVB.

OVB share price was suspended from AIM on 7 May 2025.

 

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings